KDA Group - Open Health | Smart Health
  • Home
  • Corporate Information
  • Leadership Team
  • Financial Information
  • Media
  • Contact
  • Français
Select Page

Condensed Consolidated Interim Financial Statements

by kdamaster | Dec 22, 2017 | Sedar | 0 comments

Condensed Consolidated Interim Financial Statements

VIEW THE REPORT

Recent Posts

  • KDA Group annouces the appointment of Dr Giuseppe D’Aprano as Chief Scientific Officer
  • KDA Group completes previously announced sales of a majority stake in Pharmapar
  • KDA Group signed a share purchase agreement with Strides for the sales of majority stake in Pharmapar
  • KDA Group has signed a letter of intent with Strides for the sales of a majority stake in Pharmapar
  • KDA Group not to proceed with the project to distribute the ZRx Prescriber in the United States

Recent Comments

    Archives

    • July 2019
    • February 2019
    • December 2018
    • August 2018
    • July 2018
    • June 2018
    • March 2018
    • January 2018
    • December 2017
    • June 2017
    • January 2017
    • October 2016
    • August 2016
    • July 2016
    • January 2016
    • December 2015
    • September 2015
    • June 2015
    • January 2015

    Categories

    • Market Wired
    • Non classé
    • Sedar
    • TSX

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org